Table 2.
Univariate and multivariate analyses of prognostic factors for overall survival in patients with invasive cervical cancer.
| n | Univariate analysis |
Multivariate analysis | |||
|---|---|---|---|---|---|
| 10y-OS | P value | Hazard Ratio (95%CI) | P value | ||
| Age | |||||
| < 50 | 80 | 0.84 | 0.85 | 2.52 (1.01–6.46) | 0.048 |
| ≧ 50 | 57 | 0.82 | 1 | ||
| FIGO stage | |||||
| III/IV | 43 | 0.57 | < 0.0001 | 18.9 (6.50–68.7) | < 0.0001 |
| I/II | 94 | 0.95 | 1 | ||
| Histology | |||||
| Non-SCC | 16 | 0.86 | 0.68 | 0.95 (0.15–3.51) | 0.95 |
| SCC | 121 | 0.83 | 1 | ||
| HPV16 DNA | |||||
| Positive | 59 | 0.88 | 0.30 | 0.42 (0.15 − 1.04) | 0.06 |
| Negative | 78 | 0.80 | 1 | ||
Abbreviations: HPV, human papillomavirus; FIGO, The International Federation of Gynecology and Obstetrics; SCC, squamous cell carcinoma; 10y-OS, 10 year-overall survival; 95%CI, 95% confidence interval.